The Power of an Omnichannel Network: Insights from HLTH
Blogs About
Affordability & Adherence
Insights from HLTH: Promoting Medication Affordability with AI and RWD
During my recent session at HLTH, I had the great opportunity to share a case study on how AI and real world data (RWD) increased medication affordability for patients by...
Secrets of the Data Ninjas: Takeaways from Digital Pharma East
Real-World Data (RWD) has become an essential element of pharmaceutical marketing, but as an industry we are far from utilizing its full potential. During my recent session...
Hub and Specialty Pharmacy Models West Takeaways: Overcoming Prior Authorization Hurdles with Technology
Overcoming Disadvantaged Access Positions with Digital Tools at the Point-of-Care
In almost every therapy area, utilization management, prior authorizations, and step therapy...
Increased Osteoarthritis Brand Awareness and Prescribing Through Copay Promotion
There are more than 100 different types of arthritis, but osteoarthritis (OA) is the most common—impacting 32.5 Million US adults and creating an overall economic burden of...
Addressing Medication Affordability in Vulnerable Patients During COVID-19
Pre-existing condition. This is a term we heard thrown around a lot at the start of 2020. It’s still a part of our day-to-day vocabulary, especially if you're one of the...
Improving Access to Mental Healthcare with OptimizeRx Financial Messaging
The 2022 State of Mental Health in America report highlights that 24.7% of adults with a mental illness in 2019 reported an unmet need for treatment—this number has seen a...
Overcoming Challenges Related to Multiple Sclerosis Treatment: The Complete Picture
Overcoming Challenges Related to Multiple Sclerosis Treatment: Patient Adherence
Part Three of Our Multiple Sclerosis Series
In our first two blog posts on challenges related to multiple sclerosis (MS) treatment, we addressed the need to build awareness...
Overcoming Challenges Related to Multiple Sclerosis Treatment: Initiating Treatment
Part Two of Our Multiple Sclerosis Series
In our initial blog post on challenges related to multiple sclerosis (MS) treatments, we discussed the first barrier, which is...
Omnichannel Strategy Insights from Digital Pharma East 2021
Omnichannel marketing continues to be a hot topic among pharma brand teams, but too often I see our clients struggling to convert their tactics and strategies into a true...
Access and Affordability Trends in Rare and Orphan Disease
An astounding 7,000 rare and orphan diseases affect more than 30 million people in the United States alone1. Rare diseases are classified as any disease that affects less...